🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to assess the safety and intraocular pressure...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2011-02
Trial ID
NCT01336569
Treatments Being Tested
The purpose of this study is to demonstrate superior intraocular pressure (...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02003391
The purpose of this study was to assess the efficacy and tolerability of ch...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01327599
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of transitio...
Status
Completed
Location
Mainz
Start Date
2007-08
Trial ID
NCT00519753
Treatments Being Tested
This is a single-center, cross-over comparison parallel group randomized tr...
Status
Completed
Location
Ophthalmology Department, Hospital Kuala Lumpur
Start Date
2010-08
Trial ID
NCT01168414
The purpose of this study is evaluate adherence to DuoTrav® when reinforced...
Status
Completed
Location
France
Start Date
2008-05
Trial ID
NCT00676637
Treatments Being Tested
To demonstrate superiority of DuoTrav APS over XALACOM® in Ocular Surface H...
Status
Terminated
Location
Cliniques Universitaires Saint Luc
Start Date
2010-03
Trial ID
NCT00912054
Treatments Being Tested
The primary objective of this crossover trial is to compare the 3-month, me...
Status
Completed
Location
Glaucoma Unit, 1st University Department of Ophthalmology
Start Date
2012-01
Trial ID
NCT01779284
Treatments Being Tested
The purpose of this study is to evaluate the additive intraocular pressure ...
Status
Terminated
Location
Contact Alcon for Locations (Europe, Asia, and Latin America)
Start Date
2016-06-24
Trial ID
NCT02730871
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560